Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma
{{output}}
Introduction: Serum soluble B-cell maturation antigen (sBCMA) has been shown to correspond to high disease burden in uncontrolled Multiple Myeloma (MM). However, it has not been extensively evaluated as a biomarker of minimal/mea... ...
